DFTX
#1308
Definium Therapeutics, Inc. - Common Shares
36.9 0 USD
+0.08%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+7.96%
Variación mensual
-15.17%
Variación en los últimos 6 meses
+71.39%
Cambio anual
+144.21%
Cierres anteriores
34.1 8
Open
34.8 5
Mínimo
34.5 7
Máximo
38.0 4
Financials
- Market Capitalization 4.96 B
- Employee 106
- Founded 2010
- CEO Robert Barrow
- Website www.definiumtx.com
- Headquarter British Columbia, Canada
- FIGI BBG00F13HYQ7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1285 |  CRSP CRISPR Therapeutics AG - Common Shares | 53.39 USD | +5.85% | -3.21% | +3.83% | -28.90% | 5.16 B USD | ||
| 1287 |  SRRK Scholar Rock Holding Corporation - Common Stock | 42.19 USD | -0.02% | -10.29% | -25.34% | +40.54% | 5.14 B USD | ||
| 1318 |  TVTX Travere Therapeutics, Inc. - Common Stock | 52.13 USD | +0.17% | -9.04% | -21.22% | +81.20% | 4.91 B USD | ||
| 1366 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 82.37 USD | -0.07% | -6.86% | -23.98% | +138.34% | 4.61 B USD |